UroPharma is a MedTech company focused on global commercialization of innovative and potentially disruptive therapeutic technology to treat a broad range of urinary tract disorders. UroPharma's patented drug-delivery device, dtb-instilla™ minimizes the negative side effects of conventional systemic forms of treatment by dispensing the medications directly into the bladder, direct-to-bladder (dtb) therapy.
| Website | http://www.uropharma.com |
| Revenue | $5 million |
| Employees | 12 (0 on RocketReach) |
| Founded | 2012 |
| Address | Colney Lane, Norwich Research Park, Norwich, England NR4 7UG, GB |
| Phone | +44 1603 626960 |
| Technologies |
JavaScript
,
HTML
,
PHP
+8 more
(view full list)
|
| Industry | Medical Equipment Manufacturing, Manufacturing General, Manufacturing |
| Keywords | Urology, Medicaldevices, Medtech, Menshealth, Womenshealth, Therapeutics, Healthtech, Bladder, Incontinence, Pharmaceutical, Innovation, Commercialization, Technology, Prostate, Patientcare, Healthcare |
| Competitors | Roche, Novartis, Merck AH, AbbVie, Pfizer, Bayer, GSK, AstraZeneca, Boehringer Ingelheim, アステラス製薬（株） +41 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular UroPharma employee's phone or email?
UroPharma Questions
The UroPharma annual revenue was $5 million in 2026.
UroPharma is based in Norwich, England.
The NAICS codes for UroPharma are [32541, 32, 325, 3254].
The SIC codes for UroPharma are [28, 283].
